Clinical Trial Update: Brachytherapy in Treating Patients With Recurrent Malignant Glioma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating brachytherapy for recurrent malignant glioma has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED